Significant Condensed Consolidated Balance Sheet Components	3 Months Ended
Mar. 31, 2026
Significant Consolidated Balance Sheet Components [Abstract]
Significant Condensed Consolidated Balance Sheet Components	Significant Condensed Consolidated Balance Sheet Components During the three months ended March 31, 2026, the Company made a strategic investment of $2.0 million in equity securities of a privately-held company over which the Company does not exercise significant influence. These equity securities do not have a readily determinable fair value and are accounted for under the measurement alternative. Under the measurement alternative, the carrying value of the security is measured at cost less any impairment, and adjusted for changes resulting from observable price changes in orderly transactions for identical or similar securities of the same issuer. An equity security without a readily determinable fair value is considered impaired when the fair value of the Company’s interest is less than the carrying value. Equity investments without readily determinable fair values are included in other assets on the Company’s condensed consolidated balance sheet, and any related gains or losses would be included in other gains (losses), net on the Company’s condensed consolidated statements of operations. Equity investments without readily determinable fair values were $2.0 million as of March 31, 2026, and there were no related changes in carrying amount or impairment during three months ended March 31, 2026. Property, equipment and software, net includes capitalized software development costs, net of accumulated amortization, of $28.5 million and $29.7 million as of March 31, 2026 and December 31, 2025, respectively. The Company capitalized $4.5 million and $5.1 million of software development costs during the three months ended March 31, 2026 and 2025, respectively. The Company recorded amortization expense related to capitalized software development costs of $5.7 million and $8.8 million during the three months ended March 31, 2026 and 2025, respectively. Accrued expenses and other current liabilities includes unbilled accounts payable of $45.1 million and $46.9 million, short‑term borrowings under a warehouse line of credit of $14.9 million and $6.9 million, and operating lease liabilities of $2.0 million and $1.9 million, as of March 31, 2026 and December 31, 2025, respectively. Other liabilities—noncurrent includes operating lease liabilities of $5.6 million and $6.1 million as of March 31, 2026 and December 31, 2025, respectively.

During the three months ended March 31, 2026, the Company made a strategic investment of $2.0 million in equity securities of a privately-held company over which the Company does not exercise significant influence. These equity securities do not have a readily determinable fair value and are accounted for under the measurement alternative. Under the measurement alternative, the carrying value of the security is measured at cost less any impairment, and adjusted for changes resulting from observable price changes in orderly transactions for identical or similar securities of the same issuer. An equity security without a readily determinable fair value is considered impaired when the fair value of the Company’s interest is less than the carrying value. Equity investments without readily determinable fair values are included in other assets on the Company’s condensed consolidated balance sheet, and any related gains or losses would be included in other gains (losses), net on the Company’s condensed consolidated statements of operations. Equity investments without readily determinable fair values were $2.0 million as of March 31, 2026, and there were no related changes in carrying amount or impairment during three months ended March 31, 2026.

Property, equipment and software, net includes capitalized software development costs, net of accumulated amortization, of $28.5 million and $29.7 million as of March 31, 2026 and December 31, 2025, respectively. The Company capitalized $4.5 million and $5.1 million of software development costs during the three months ended March 31, 2026 and 2025, respectively. The Company recorded amortization expense related to capitalized software development costs of $5.7 million and $8.8 million during the three months ended March 31, 2026 and 2025, respectively.

Accrued expenses and other current liabilities includes unbilled accounts payable of $45.1 million and $46.9 million, short‑term borrowings under a warehouse line of credit of $14.9 million and $6.9 million, and operating lease liabilities of $2.0 million and $1.9 million, as of March 31, 2026 and December 31, 2025, respectively.